A CLINICAL STUDY OF RUBRICS OF RINGWORM FROM KNERR REPERTORY
- Conditions
- Tinea corporis,
- Registration Number
- CTRI/2023/05/053117
- Lead Sponsor
- KHUSHALI KUBERBHAI PATEL
- Brief Summary
SKIN DISEASES ARE MAJOR HEALTH PROBLEM AFFECTING A HIGH PROPORTION OF POPULATION OF INDIA SKIN DISEASE CAN PLACE A HEAVY EMOTIONAL AND PSYCHOLOGICAL BURDEN ON PATIENTS THAT MAY BE FAR WORSE THAN PHYSICAL IMPACT THE STUDY WILL BE EXPERIMENTAL AND INTERVENTIONAL UNCONTROLLED TRIAL A STUDY WILL BE CONDUCTED WITH 34 SAMPLES AND WHICH WILL BE SELECTED FROM 2 PROJECT SITE ON BASIS OF INCLUSION AND EXCLUSION CRITERIA THROUGH PURPOSIVE SAMPLING CONSENT WILL BE TAKEN OF CHOSEN CASES CASE TAKING WILL BE DONE ACCORDING TO GUIDELINES MENTIONED BY DR HAHNEMANN IN APHORISMS NUMBER 83 TO 104 FURTHER CASE PROCESSING WILL BE DONE USING ZOMEO SOFTWARE OR BOOK FORM OF KNERR REPERTORY TO DIFFERENTIATE GROUP OF MEDICINES HERING GUIDING SYMPTOM OF OUR MATERIA MEDICA WILL BE USED CHOSEN REMEDY WILL BE GIVEN IN VARIOUS POTENCY AS PER REQUIREMENT OF CASES. THE FOLLOW UP BE TAKEN USING RINGWORM SYMPTOM SCORE AT 7 15 OR 21 DAYS INTERVALAS PER CASE REQUIREMENT AFTER CESSEATION OF TREATMENT PATIENT WILL BE FOLLOWED UP FOR AT LEAST 3 MONTHS TO CHECK RELAPSE ANALYSIS OF RESULT WILL BE DONE ACCORDING TO RESPONSE OBTAINED AFTER TREATMENT THE PERCENTAGE CRITERIA FOR PARTICULAR CASE WILL BE OBTAINED WITH USE OF RINGWORM SYMPTOM SCORE STATISTICAL ANALYSIS WILL BE DONE WITH PAIRED T-TEST THE EXPECTED RESULT WILL BE EITHER SIGNIFICANT OR NO USEFULNESS OF RUBRICS OF RINGWORM FROM KNERR REPERTORY IN TREATING THE CASES OF RINGWORM
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 34
DIAGNOSED CASES OR CASES WITH CLINICAL PRESENTATION OF RINGWORM.
CASES OF RINGWORM WITH AIDS CASES OF RINGWORM COMPLICATED WITH OTHER SKIN COMPLAINT CASES OF RINGWORM WITH SEVERELY IMMUNOCOMPROMISED STATE CASES OF RINGWORM IN PREGNANT WOMEN.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method RINGWORM SYMPTOM SCORE FOLLOW UP WILL BE TAKEN ON 7 15 21 DAYS AS PER CASE REQUIREMENT
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
SMT S I PATEL (IPCOWALA) HOMOEOPATHIC HOSPITAL
🇮🇳Anand, GUJARAT, India
SMT S I PATEL (IPCOWALA) HOMOEOPATHIC HOSPITAL🇮🇳Anand, GUJARAT, IndiaDR MEERA SHAHPrincipal investigator9898692003dr.meerashah@yahoo.com